nodes	percent_of_prediction	percent_of_DWPC	metapath
Levomilnacipran—SLC6A4—endogenous depression	0.511	0.587	CbGaD
Levomilnacipran—CYP2D6—endogenous depression	0.359	0.413	CbGaD
Levomilnacipran—SLC6A2—locus ceruleus—endogenous depression	0.0106	0.158	CbGeAlD
Levomilnacipran—SLC6A2—sympathetic nervous system—endogenous depression	0.0084	0.125	CbGeAlD
Levomilnacipran—SLC6A2—autonomic nervous system—endogenous depression	0.00565	0.0839	CbGeAlD
Levomilnacipran—Milnacipran—SLC6A4—endogenous depression	0.0043	0.694	CrCbGaD
Levomilnacipran—CYP2J2—Fatty acids—CYP2D6—endogenous depression	0.00424	0.0745	CbGpPWpGaD
Levomilnacipran—SLC6A4—Serotonin Transporter Activity—TPH2—endogenous depression	0.00391	0.0686	CbGpPWpGaD
Levomilnacipran—CYP2J2—Xenobiotics—CYP2D6—endogenous depression	0.00337	0.0592	CbGpPWpGaD
Levomilnacipran—CYP2J2—Tryptophan metabolism—TPH1—endogenous depression	0.00286	0.0501	CbGpPWpGaD
Levomilnacipran—CYP2J2—forebrain—endogenous depression	0.00277	0.0412	CbGeAlD
Levomilnacipran—SLC6A4—Serotonin Transporter Activity—MAOA—endogenous depression	0.00235	0.0412	CbGpPWpGaD
Levomilnacipran—CYP2J2—cardiovascular system—endogenous depression	0.00234	0.0348	CbGeAlD
Levomilnacipran—CYP2J2—pituitary gland—endogenous depression	0.00208	0.0308	CbGeAlD
Levomilnacipran—CYP2J2—midbrain—endogenous depression	0.00183	0.0272	CbGeAlD
Levomilnacipran—CYP2J2—thyroid gland—endogenous depression	0.00179	0.0266	CbGeAlD
Levomilnacipran—SLC6A4—Monoamine Transport—TPH2—endogenous depression	0.00166	0.0292	CbGpPWpGaD
Levomilnacipran—CYP2J2—endocrine gland—endogenous depression	0.00161	0.0239	CbGeAlD
Levomilnacipran—CYP3A4—Farnesoid X Receptor  Pathway—FKBP5—endogenous depression	0.00159	0.0279	CbGpPWpGaD
Levomilnacipran—SLC6A4—brainstem—endogenous depression	0.00155	0.023	CbGeAlD
Levomilnacipran—ABCB1—Codeine and Morphine Metabolism—CYP2D6—endogenous depression	0.00153	0.0268	CbGpPWpGaD
Levomilnacipran—CYP2J2—nervous system—endogenous depression	0.00151	0.0224	CbGeAlD
Levomilnacipran—SLC6A4—forebrain—endogenous depression	0.00149	0.0222	CbGeAlD
Levomilnacipran—CYP2J2—central nervous system—endogenous depression	0.00145	0.0215	CbGeAlD
Levomilnacipran—SLC6A2—Monoamine Transport—TPH2—endogenous depression	0.00143	0.0251	CbGpPWpGaD
Levomilnacipran—CYP2J2—cerebellum—endogenous depression	0.00142	0.021	CbGeAlD
Levomilnacipran—CYP2J2—Cytochrome P450 - arranged by substrate type—CYP2D6—endogenous depression	0.0014	0.0246	CbGpPWpGaD
Levomilnacipran—CYP2J2—Oxidation by Cytochrome P450—CYP2D6—endogenous depression	0.00138	0.0242	CbGpPWpGaD
Levomilnacipran—SLC6A2—brainstem—endogenous depression	0.00136	0.0203	CbGeAlD
Levomilnacipran—CYP2C8—CYP2E1 reactions—CYP2D6—endogenous depression	0.00136	0.0238	CbGpPWpGaD
Levomilnacipran—SLC6A2—forebrain—endogenous depression	0.00132	0.0196	CbGeAlD
Levomilnacipran—CYP2C19—CYP2E1 reactions—CYP2D6—endogenous depression	0.00121	0.0213	CbGpPWpGaD
Levomilnacipran—CYP2J2—brain—endogenous depression	0.00115	0.0171	CbGeAlD
Levomilnacipran—SLC6A2—Monoamine Transport—SLC6A4—endogenous depression	0.00114	0.0201	CbGpPWpGaD
Levomilnacipran—CYP2J2—Phase 1 - Functionalization of compounds—CYP2D6—endogenous depression	0.00113	0.0199	CbGpPWpGaD
Levomilnacipran—Pethidine—SLC6A4—endogenous depression	0.00111	0.18	CrCbGaD
Levomilnacipran—SLC6A4—midbrain—endogenous depression	0.000987	0.0147	CbGeAlD
Levomilnacipran—CYP3A4—Codeine and Morphine Metabolism—CYP2D6—endogenous depression	0.00094	0.0165	CbGpPWpGaD
Levomilnacipran—SLC6A2—adrenal gland—endogenous depression	0.00088	0.0131	CbGeAlD
Levomilnacipran—SLC6A4—endocrine gland—endogenous depression	0.000867	0.0129	CbGeAlD
Levomilnacipran—CYP2J2—Phase 1 - Functionalization of compounds—MAOA—endogenous depression	0.000854	0.015	CbGpPWpGaD
Levomilnacipran—CYP2C8—Xenobiotics—CYP2D6—endogenous depression	0.000842	0.0148	CbGpPWpGaD
Levomilnacipran—SLC6A4—nervous system—endogenous depression	0.000812	0.0121	CbGeAlD
Levomilnacipran—CYP2C8—pituitary gland—endogenous depression	0.000809	0.012	CbGeAlD
Levomilnacipran—CYP2C8—Tamoxifen metabolism—CYP2D6—endogenous depression	0.000809	0.0142	CbGpPWpGaD
Levomilnacipran—Pethidine—CYP2D6—endogenous depression	0.000782	0.126	CrCbGaD
Levomilnacipran—SLC6A4—central nervous system—endogenous depression	0.000781	0.0116	CbGeAlD
Levomilnacipran—SLC6A2—endocrine gland—endogenous depression	0.000763	0.0113	CbGeAlD
Levomilnacipran—CYP2C19—Xenobiotics—CYP2D6—endogenous depression	0.000751	0.0132	CbGpPWpGaD
Levomilnacipran—CYP2D6—brainstem—endogenous depression	0.000747	0.0111	CbGeAlD
Levomilnacipran—CYP2C19—Tamoxifen metabolism—CYP2D6—endogenous depression	0.000722	0.0127	CbGpPWpGaD
Levomilnacipran—CYP2D6—forebrain—endogenous depression	0.000721	0.0107	CbGeAlD
Levomilnacipran—CYP2C19—endocrine gland—endogenous depression	0.000718	0.0107	CbGeAlD
Levomilnacipran—SLC6A2—nervous system—endogenous depression	0.000714	0.0106	CbGeAlD
Levomilnacipran—SLC6A2—central nervous system—endogenous depression	0.000688	0.0102	CbGeAlD
Levomilnacipran—CYP2J2—Cytochrome P450 - arranged by substrate type—POMC—endogenous depression	0.000686	0.012	CbGpPWpGaD
Levomilnacipran—CYP2C8—endocrine gland—endogenous depression	0.000627	0.00932	CbGeAlD
Levomilnacipran—SLC6A4—brain—endogenous depression	0.00062	0.00921	CbGeAlD
Levomilnacipran—SLC6A4—SIDS Susceptibility Pathways—TPH1—endogenous depression	0.000618	0.0108	CbGpPWpGaD
Levomilnacipran—CYP2J2—Biological oxidations—CYP2D6—endogenous depression	0.000603	0.0106	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metapathway biotransformation—CYP2D6—endogenous depression	0.000595	0.0104	CbGpPWpGaD
Levomilnacipran—CYP2C19—Melatonin metabolism and effects—CYP2D6—endogenous depression	0.000558	0.00979	CbGpPWpGaD
Levomilnacipran—CYP2J2—Phase 1 - Functionalization of compounds—POMC—endogenous depression	0.000556	0.00976	CbGpPWpGaD
Levomilnacipran—SLC6A2—brain—endogenous depression	0.000546	0.00811	CbGeAlD
Levomilnacipran—CYP3A4—Fatty Acid Omega Oxidation—CYP2D6—endogenous depression	0.00054	0.00948	CbGpPWpGaD
Levomilnacipran—ABCB1—forebrain—endogenous depression	0.000518	0.0077	CbGeAlD
Levomilnacipran—SLC6A4—Circadian rythm related genes—TPH1—endogenous depression	0.000505	0.00885	CbGpPWpGaD
Levomilnacipran—ABCB1—adrenal cortex—endogenous depression	0.00048	0.00714	CbGeAlD
Levomilnacipran—SLC6A4—SIDS Susceptibility Pathways—TPH2—endogenous depression	0.000468	0.00822	CbGpPWpGaD
Levomilnacipran—CYP2J2—Biological oxidations—COMT—endogenous depression	0.000457	0.00802	CbGpPWpGaD
Levomilnacipran—CYP2J2—Biological oxidations—MAOA—endogenous depression	0.000454	0.00796	CbGpPWpGaD
Levomilnacipran—CYP3A4—Xenobiotics—CYP2D6—endogenous depression	0.000452	0.00793	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metapathway biotransformation—COMT—endogenous depression	0.000451	0.00791	CbGpPWpGaD
Levomilnacipran—CYP2C8—brain—endogenous depression	0.000449	0.00666	CbGeAlD
Levomilnacipran—ABCB1—cardiovascular system—endogenous depression	0.000438	0.00651	CbGeAlD
Levomilnacipran—CYP3A4—Tamoxifen metabolism—CYP2D6—endogenous depression	0.000434	0.00762	CbGpPWpGaD
Levomilnacipran—CYP3A4—endocrine gland—endogenous depression	0.000425	0.00631	CbGeAlD
Levomilnacipran—CYP2C19—Melatonin metabolism and effects—MAOA—endogenous depression	0.00042	0.00737	CbGpPWpGaD
Levomilnacipran—CYP2D6—endocrine gland—endogenous depression	0.000418	0.00621	CbGeAlD
Levomilnacipran—CYP3A4—nervous system—endogenous depression	0.000398	0.00591	CbGeAlD
Levomilnacipran—CYP2D6—nervous system—endogenous depression	0.000391	0.00581	CbGeAlD
Levomilnacipran—ABCB1—pituitary gland—endogenous depression	0.000388	0.00577	CbGeAlD
Levomilnacipran—SLC6A4—SIDS Susceptibility Pathways—HTR1A—endogenous depression	0.000388	0.0068	CbGpPWpGaD
Levomilnacipran—CYP2D6—Melatonin metabolism and effects—MAOA—endogenous depression	0.000386	0.00678	CbGpPWpGaD
Levomilnacipran—CYP3A4—Tryptophan metabolism—TPH1—endogenous depression	0.000383	0.00672	CbGpPWpGaD
Levomilnacipran—CYP3A4—central nervous system—endogenous depression	0.000383	0.00569	CbGeAlD
Levomilnacipran—SLC6A4—Circadian rythm related genes—TPH2—endogenous depression	0.000382	0.00671	CbGpPWpGaD
Levomilnacipran—CYP2D6—central nervous system—endogenous depression	0.000377	0.0056	CbGeAlD
Levomilnacipran—SLC6A4—SIDS Susceptibility Pathways—GATA3—endogenous depression	0.000374	0.00657	CbGpPWpGaD
Levomilnacipran—CYP3A4—Estrogen metabolism—COMT—endogenous depression	0.000372	0.00654	CbGpPWpGaD
Levomilnacipran—CYP2D6—cerebellum—endogenous depression	0.000368	0.00547	CbGeAlD
Levomilnacipran—ABCB1—HIF-1-alpha transcription factor network—ADM—endogenous depression	0.000362	0.00635	CbGpPWpGaD
Levomilnacipran—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2D6—endogenous depression	0.000349	0.00613	CbGpPWpGaD
Levomilnacipran—ABCB1—adrenal gland—endogenous depression	0.000347	0.00515	CbGeAlD
Levomilnacipran—CYP2C8—Oxidation by Cytochrome P450—CYP2D6—endogenous depression	0.000345	0.00605	CbGpPWpGaD
Levomilnacipran—ABCB1—midbrain—endogenous depression	0.000342	0.00509	CbGeAlD
Levomilnacipran—SLC6A2—NRF2 pathway—SLC6A4—endogenous depression	0.000339	0.00596	CbGpPWpGaD
Levomilnacipran—ABCB1—thyroid gland—endogenous depression	0.000335	0.00497	CbGeAlD
Levomilnacipran—SLC6A4—Circadian rythm related genes—CRH—endogenous depression	0.000329	0.00577	CbGpPWpGaD
Levomilnacipran—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2D6—endogenous depression	0.000312	0.00547	CbGpPWpGaD
Levomilnacipran—CYP2C19—Oxidation by Cytochrome P450—CYP2D6—endogenous depression	0.000308	0.0054	CbGpPWpGaD
Levomilnacipran—ABCB1—endocrine gland—endogenous depression	0.000301	0.00447	CbGeAlD
Levomilnacipran—CYP2D6—brain—endogenous depression	0.000299	0.00444	CbGeAlD
Levomilnacipran—CYP2J2—Biological oxidations—POMC—endogenous depression	0.000295	0.00518	CbGpPWpGaD
Levomilnacipran—CYP2C8—Phase 1 - Functionalization of compounds—CYP2D6—endogenous depression	0.000283	0.00497	CbGpPWpGaD
Levomilnacipran—SLC6A4—SIDS Susceptibility Pathways—MAOA—endogenous depression	0.000282	0.00494	CbGpPWpGaD
Levomilnacipran—ABCB1—nervous system—endogenous depression	0.000281	0.00418	CbGeAlD
Levomilnacipran—SLC6A4—SIDS Susceptibility Pathways—BDNF—endogenous depression	0.000272	0.00477	CbGpPWpGaD
Levomilnacipran—ABCB1—central nervous system—endogenous depression	0.000271	0.00402	CbGeAlD
Levomilnacipran—SLC6A4—Circadian rythm related genes—HTR7—endogenous depression	0.000268	0.0047	CbGpPWpGaD
Levomilnacipran—ABCB1—cerebellum—endogenous depression	0.000265	0.00393	CbGeAlD
Levomilnacipran—SLC6A4—SIDS Susceptibility Pathways—IL10—endogenous depression	0.000259	0.00455	CbGpPWpGaD
Levomilnacipran—CYP2C19—Phase 1 - Functionalization of compounds—CYP2D6—endogenous depression	0.000253	0.00444	CbGpPWpGaD
Levomilnacipran—SLC6A4—SIDS Susceptibility Pathways—NR3C1—endogenous depression	0.00024	0.00421	CbGpPWpGaD
Levomilnacipran—SLC6A4—SIDS Susceptibility Pathways—HTR2A—endogenous depression	0.00023	0.00403	CbGpPWpGaD
Levomilnacipran—ABCB1—brain—endogenous depression	0.000215	0.0032	CbGeAlD
Levomilnacipran—CYP2C8—Phase 1 - Functionalization of compounds—MAOA—endogenous depression	0.000213	0.00374	CbGpPWpGaD
Levomilnacipran—CYP2C19—Phase 1 - Functionalization of compounds—MAOA—endogenous depression	0.00019	0.00334	CbGpPWpGaD
Levomilnacipran—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—endogenous depression	0.000188	0.00329	CbGpPWpGaD
Levomilnacipran—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—endogenous depression	0.000185	0.00325	CbGpPWpGaD
Levomilnacipran—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—endogenous depression	0.000175	0.00307	CbGpPWpGaD
Levomilnacipran—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—endogenous depression	0.000171	0.003	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—TPH1—endogenous depression	0.00017	0.00299	CbGpPWpGaD
Levomilnacipran—ABCB1—Allograft Rejection—IL10—endogenous depression	0.000169	0.00297	CbGpPWpGaD
Levomilnacipran—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—endogenous depression	0.000153	0.00268	CbGpPWpGaD
Levomilnacipran—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—endogenous depression	0.000152	0.00267	CbGpPWpGaD
Levomilnacipran—CYP2C8—Biological oxidations—CYP2D6—endogenous depression	0.00015	0.00264	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metapathway biotransformation—CYP2D6—endogenous depression	0.000148	0.0026	CbGpPWpGaD
Levomilnacipran—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—endogenous depression	0.000141	0.00247	CbGpPWpGaD
Levomilnacipran—CYP2C8—Phase 1 - Functionalization of compounds—POMC—endogenous depression	0.000139	0.00244	CbGpPWpGaD
Levomilnacipran—CYP2C19—Biological oxidations—CYP2D6—endogenous depression	0.000134	0.00236	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metapathway biotransformation—CYP2D6—endogenous depression	0.000132	0.00232	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—CACNB2—endogenous depression	0.000129	0.00226	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—TPH2—endogenous depression	0.000129	0.00226	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—DPYD—endogenous depression	0.000127	0.00223	CbGpPWpGaD
Levomilnacipran—CYP2C19—Phase 1 - Functionalization of compounds—POMC—endogenous depression	0.000124	0.00217	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—CACNA1C—endogenous depression	0.000118	0.00207	CbGpPWpGaD
Levomilnacipran—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—endogenous depression	0.000114	0.00201	CbGpPWpGaD
Levomilnacipran—CYP2C8—Biological oxidations—COMT—endogenous depression	0.000114	0.002	CbGpPWpGaD
Levomilnacipran—CYP2D6—Phase 1 - Functionalization of compounds—POMC—endogenous depression	0.000114	0.002	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism of lipids and lipoproteins—POMC—endogenous depression	0.000113	0.00199	CbGpPWpGaD
Levomilnacipran—CYP2C8—Biological oxidations—MAOA—endogenous depression	0.000113	0.00199	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metapathway biotransformation—COMT—endogenous depression	0.000112	0.00197	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—CYP2D6—endogenous depression	0.000103	0.00181	CbGpPWpGaD
Levomilnacipran—CYP2C19—Biological oxidations—COMT—endogenous depression	0.000102	0.00179	CbGpPWpGaD
Levomilnacipran—CYP2C19—Biological oxidations—MAOA—endogenous depression	0.000101	0.00177	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metapathway biotransformation—COMT—endogenous depression	0.0001	0.00176	CbGpPWpGaD
Levomilnacipran—CYP2D6—Biological oxidations—COMT—endogenous depression	9.36e-05	0.00164	CbGpPWpGaD
Levomilnacipran—CYP2D6—Biological oxidations—MAOA—endogenous depression	9.3e-05	0.00163	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metapathway biotransformation—COMT—endogenous depression	9.23e-05	0.00162	CbGpPWpGaD
Levomilnacipran—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—endogenous depression	9.19e-05	0.00161	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—endogenous depression	8.75e-05	0.00154	CbGpPWpGaD
Levomilnacipran—CYP3A4—Biological oxidations—CYP2D6—endogenous depression	8.08e-05	0.00142	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metapathway biotransformation—CYP2D6—endogenous depression	7.97e-05	0.0014	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—COMT—endogenous depression	7.81e-05	0.00137	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—MAOA—endogenous depression	7.76e-05	0.00136	CbGpPWpGaD
Levomilnacipran—CYP3A4—Phase 1 - Functionalization of compounds—POMC—endogenous depression	7.45e-05	0.00131	CbGpPWpGaD
Levomilnacipran—CYP2C8—Biological oxidations—POMC—endogenous depression	7.37e-05	0.00129	CbGpPWpGaD
Levomilnacipran—CYP2C19—Biological oxidations—POMC—endogenous depression	6.58e-05	0.00115	CbGpPWpGaD
Levomilnacipran—CYP3A4—Biological oxidations—COMT—endogenous depression	6.12e-05	0.00107	CbGpPWpGaD
Levomilnacipran—CYP3A4—Biological oxidations—MAOA—endogenous depression	6.08e-05	0.00107	CbGpPWpGaD
Levomilnacipran—CYP2D6—Biological oxidations—POMC—endogenous depression	6.05e-05	0.00106	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metapathway biotransformation—COMT—endogenous depression	6.04e-05	0.00106	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—POMC—endogenous depression	5.05e-05	0.000886	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—TPH1—endogenous depression	4.25e-05	0.000745	CbGpPWpGaD
Levomilnacipran—CYP3A4—Biological oxidations—POMC—endogenous depression	3.96e-05	0.000694	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—TPH1—endogenous depression	3.79e-05	0.000665	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—TPH1—endogenous depression	3.7e-05	0.000649	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—TPH1—endogenous depression	3.49e-05	0.000612	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—CACNB2—endogenous depression	3.22e-05	0.000565	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—TPH2—endogenous depression	3.22e-05	0.000565	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—DPYD—endogenous depression	3.17e-05	0.000556	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—CACNA1C—endogenous depression	2.94e-05	0.000517	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—TPH2—endogenous depression	2.87e-05	0.000504	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—CACNB2—endogenous depression	2.87e-05	0.000504	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—POMC—endogenous depression	2.83e-05	0.000497	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—DPYD—endogenous depression	2.83e-05	0.000496	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—CACNB2—endogenous depression	2.8e-05	0.000492	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—TPH2—endogenous depression	2.8e-05	0.000492	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—DPYD—endogenous depression	2.76e-05	0.000484	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—TPH2—endogenous depression	2.64e-05	0.000464	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—CACNB2—endogenous depression	2.64e-05	0.000464	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—CACNA1C—endogenous depression	2.63e-05	0.000461	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—DPYD—endogenous depression	2.6e-05	0.000456	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—CYP2D6—endogenous depression	2.57e-05	0.000452	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—CACNA1C—endogenous depression	2.57e-05	0.00045	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—POMC—endogenous depression	2.53e-05	0.000443	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—CACNA1C—endogenous depression	2.42e-05	0.000424	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—CYP2D6—endogenous depression	2.3e-05	0.000403	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—TPH1—endogenous depression	2.28e-05	0.0004	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—CYP2D6—endogenous depression	2.24e-05	0.000393	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—COMT—endogenous depression	1.95e-05	0.000342	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—MAOA—endogenous depression	1.94e-05	0.00034	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—COMT—endogenous depression	1.74e-05	0.000305	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—MAOA—endogenous depression	1.73e-05	0.000303	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—TPH2—endogenous depression	1.73e-05	0.000303	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—CACNB2—endogenous depression	1.73e-05	0.000303	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—DPYD—endogenous depression	1.7e-05	0.000298	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—COMT—endogenous depression	1.7e-05	0.000298	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—MAOA—endogenous depression	1.69e-05	0.000296	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—COMT—endogenous depression	1.6e-05	0.000281	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—MAOA—endogenous depression	1.59e-05	0.000279	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—CACNA1C—endogenous depression	1.58e-05	0.000277	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—CYP2D6—endogenous depression	1.38e-05	0.000242	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—POMC—endogenous depression	1.26e-05	0.000221	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—POMC—endogenous depression	1.13e-05	0.000197	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—POMC—endogenous depression	1.1e-05	0.000193	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—COMT—endogenous depression	1.05e-05	0.000184	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—MAOA—endogenous depression	1.04e-05	0.000182	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—POMC—endogenous depression	1.04e-05	0.000182	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—POMC—endogenous depression	6.77e-06	0.000119	CbGpPWpGaD
